Buchheim J, Enzinger M, Chouker A, Bruegel M, Holdt L, Rehm M. The stressed vascular barrier and coagulation - The impact of key glycocalyx components on in vitro clot formation. Thromb Res. 2020;186:93-102 pubmed publisher

Picchiarelli G, Demestre M, Zuko A, Been M, Higelin J, Dieterlé S, et al. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nat Neurosci. 2019;22:1793-1805 pubmed publisher

Ghosh K, Prakash A, Dhara A, Hussain M, Shrivastav P, Kumar P, et al. Role of Supramolecule ErpY-Like Lipoprotein of Leptospira in Thrombin-Catalyzed Fibrin Clot Inhibition and Binding to Complement Factors H and I, and Its Diagnostic Potential. Infect Immun. 2019;87: pubmed publisher

Tao L, Tian S, Zhang J, Liu Z, Robinson McCarthy L, Miyashita S, et al. Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells. Nat Microbiol. 2019;: pubmed publisher

Kopec M, Imiela A, Abramczyk H. Monitoring glycosylation metabolism in brain and breast cancer by Raman imaging. Sci Rep. 2019;9:166 pubmed publisher

Billings P, Yang E, Mundy C, Pacifici M. Domains with highest heparan sulfate-binding affinity reside at opposite ends in BMP2/4 versus BMP5/6/7: Implications for function. J Biol Chem. 2018;293:14371-14383 pubmed publisher

McNaughton E, Eustace A, King S, Sessions R, Kay A, Farris M, et al. Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis. J Immunol. 2018;200:3201-3217 pubmed publisher

Chen S, Wang H, Li H, Zhang Y, Wu Q. Functional analysis of corin protein domains required for PCSK6-mediated activation. Int J Biochem Cell Biol. 2018;94:31-39 pubmed publisher

Gebremeskel S, Lobert L, Tanner K, Walker B, Oliphant T, Clarke L, et al. Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer. Cancer Immunol Res. 2017;5:1086-1097 pubmed publisher

Kempf A, Boda E, Kwok J, Fritz R, Grande V, Kaelin A, et al. Control of Cell Shape, Neurite Outgrowth, and Migration by a Nogo-A/HSPG Interaction. Dev Cell. 2017;43:24-34.e5 pubmed publisher

Gustafsen C, Olsen D, Vilstrup J, Lund S, Reinhardt A, Wellner N, et al. Heparan sulfate proteoglycans present PCSK9 to the LDL receptor. Nat Commun. 2017;8:503 pubmed publisher

Kiran G, Prasada Rao U, Salimath P, Chilkunda N. Diet-induced hypercholesterolemia alters liver glycosaminoglycans and associated-lipoprotein receptors in rats. J Physiol Biochem. 2017;73:539-550 pubmed publisher

Thomas J, Eric Dollins D, Andrykovich K, Chu T, Stultz B, Hursh D, et al. SMOC can act as both an antagonist and an expander of BMP signaling. elife. 2017;6: pubmed publisher

Jin T, Nicholls F, Crum W, Ghuman H, Badylak S, Modo M. Diamagnetic chemical exchange saturation transfer (diaCEST) affords magnetic resonance imaging of extracellular matrix hydrogel implantation in a rat model of stroke. Biomaterials. 2017;113:176-190 pubmed publisher

Dismuke W, Klingeborn M, Stamer W. Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone. PLoS ONE. 2016;11:e0165326 pubmed publisher

Ornaghi S, Davis J, Gorres K, Miller G, Paidas M, van den Pol A. Mood stabilizers inhibit cytomegalovirus infection. Virology. 2016;499:121-135 pubmed publisher

Martin L, De Santis R, Koczera P, Simons N, Haase H, Heinbockel L, et al. The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis. PLoS ONE. 2015;10:e0143583 pubmed publisher

Teran M, Nugent M. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. J Biol Chem. 2015;290:16451-62 pubmed publisher

Ellett L, Coleman B, Shambrook M, Johanssen V, Collins S, Masters C, et al. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates. Glycobiology. 2015;25:745-55 pubmed publisher

Florine E, Miller R, Liebesny P, Mroszczyk K, Lee R, Patwari P, et al. Delivering heparin-binding insulin-like growth factor 1 with self-assembling peptide hydrogels. Tissue Eng Part A. 2015;21:637-46 pubmed publisher

Bruhl H, Cihak J, Goebel N, Talke Y, Renner K, Hermann F, et al. Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses. J Leukoc Biol. 2014;96:65-72 pubmed publisher

Benelli U, Bocci G, Danesi R, Lepri A, Bernardini N, Bianchi F, et al. The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. Exp Eye Res. 1998;67:133-42 pubmed

Fuxe K, Tinner B, Staines W, David G, Agnati L. Regional distribution of neural cell adhesion molecule immunoreactivity in the adult rat telencephalon and diencephalon. Partial colocalization with heparan sulfate proteoglycan immunoreactivity. Brain Res. 1997;746:25-33 pubmed

Tanaka Y, Kimata K, Wake A, Mine S, Morimoto I, Yamakawa N, et al. Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells. J Exp Med. 1996;184:1987-97 pubmed

Lepri A, Benelli U, Chetoni P, Perini G, Saettone M, Nardi M. Effect of suleparoide on fibrinolysis in the anterior chamber of rabbits. Ophthalmic Res. 1996;28:176-83 pubmed

Callas D, Hoppensteadt D, Jeske W, Iqbal O, Bacher P, Ahsan A, et al. Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide. Semin Thromb Hemost. 1993;19 Suppl 1:49-57 pubmed